These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 11257104)
21. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399 [TBL] [Abstract][Full Text] [Related]
22. Genes implicated in hereditary breast cancer syndromes. Tonin PN Semin Surg Oncol; 2000 Jun; 18(4):281-6. PubMed ID: 10805949 [TBL] [Abstract][Full Text] [Related]
23. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Ganguly A; Leahy K; Marshall AM; Dhulipala R; Godmilow L; Ganguly T Genet Test; 1997; 1(2):85-90. PubMed ID: 10464631 [TBL] [Abstract][Full Text] [Related]
24. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Chenevix-Trench G; Milne RL; Antoniou AC; Couch FJ; Easton DF; Goldgar DE; Breast Cancer Res; 2007; 9(2):104. PubMed ID: 17466083 [TBL] [Abstract][Full Text] [Related]
25. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978 [TBL] [Abstract][Full Text] [Related]
26. Founder populations and their uses for breast cancer genetics. Neuhausen SL Breast Cancer Res; 2000; 2(2):77-81. PubMed ID: 11250694 [TBL] [Abstract][Full Text] [Related]
27. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland. Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283 [TBL] [Abstract][Full Text] [Related]
28. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856 [TBL] [Abstract][Full Text] [Related]
29. [Breast cancer susceptibility genes]. Díez O; Gutiérrez-Enríquez S; Ramón y Cajal T Med Clin (Barc); 2006 Mar; 126(8):304-10. PubMed ID: 16527158 [TBL] [Abstract][Full Text] [Related]
30. Breast cancer genetics: what we know and what we need. Nathanson KL; Wooster R; Weber BL Nat Med; 2001 May; 7(5):552-6. PubMed ID: 11329055 [TBL] [Abstract][Full Text] [Related]
31. BRCA1 and BRCA2: from molecular genetics to clinical medicine. Blackwood MA; Weber BL J Clin Oncol; 1998 May; 16(5):1969-77. PubMed ID: 9586917 [TBL] [Abstract][Full Text] [Related]
32. Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families. Li J; Li H; Makunin I; ; Thompson BA; Tao K; Young EL; Lopez J; Camp NJ; Tavtigian SV; John EM; Andrulis IL; Khanna KK; Goldgar D; Chenevix-Trench G Breast Cancer Res Treat; 2017 Dec; 166(3):937-949. PubMed ID: 28840378 [TBL] [Abstract][Full Text] [Related]
33. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709 [TBL] [Abstract][Full Text] [Related]
34. BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC). Shen D; Vadgama JV Oncol Res; 1999; 11(2):63-9. PubMed ID: 10489161 [TBL] [Abstract][Full Text] [Related]
35. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer. Kuschel B; Lux MP; Goecke TO; Beckmann MW Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253 [TBL] [Abstract][Full Text] [Related]
37. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. Ligtenberg MJ; Hogervorst FB; Willems HW; Arts PJ; Brink G; Hageman S; Bosgoed EA; Van der Looij E; Rookus MA; Devilee P; Vos EM; Wigbout G; Struycken PM; Menko FH; Rutgers EJ; Hoefsloot EH; Mariman EC; Brunner HG; Van 't Veer LJ Br J Cancer; 1999 Mar; 79(9-10):1475-8. PubMed ID: 10188893 [TBL] [Abstract][Full Text] [Related]